Amgen Inc (NASDAQ: AMGN)
DRUGS - BiotechnologySector: Health Care
Stock price data as of 07/19/2024
Closing price: 331.29
| Support price level: | $315.01 |
| Resistance price level: | N/A |
| Relative strength index (14-day RSI) | 76.4 |
| Beta | 0.48 |
- AMGN is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- With a 42.8 percent return in the past year, this stock outperformed 90 percent of stocks in the S&P-100.
- Volatility is forecast to fall over the next month.
- With RSI > 70, AMGN is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
| Low | High | Price as % of Range |
| $230.41 | $335.67 | 96.5% |
| 200 day | 50 day | 20 day | 10 day |
| $288.82 | $311.99 | $319.64 | $326.62 |
| Historical (5 year) |
Last month | Current estimate | Next month forecast |
| 25.7% | 20.9% | 21.9% | 24.1% |
- 6.0% in the next week.
- 13.6% in the next month.
- 46.8% in the next year.
